Skip to main content

Table 1 Epidemiological, clinical, and laboratory characteristics among studied groups

From: Blood eosinophil variability in patients presenting with acute exacerbations of COPD within the past year and its correlation with treatment plan

 

Total

N = 270

EOS

N = 86

Non-EOS

N = 40

Fluctuating EOS

N = 144

P value

Age (years)

67.64 ± 10.61

67.39 ± 12.74

68.13 ± 9.08

67.65 ± 9.62

0.938

BMI (kg/m2)

30.73 ± 3.85

31.36 ± 4.89A

29.78 ± 2.35A

30.61 ± 3.42

0.09

Pack/year smoking index

64.85 ± 27.92

64 (8–124)

68 (22–136)

63 (17–124)

0.711

Length of hospital stay (days)

4.39 ± 1.22

4 (2–7)

4 (2–6)

5 (2–8)

0.147

Current smoker

 Yes

165 (61.1)

60 (69.8)

25 (62.5)

80 (55.6)

0.100

 No

105 (38.9)

26 (30.2)

15 (37.5)

64 (44.4)

 

Frequency of exacerbations/year

 > 2

 = 2

144 (53.3)

126 (46.7)

48 (55.8)

38 (44.2)

21 (52.5)

19 (47.5)

75 (52.1)

69 (47.9)

0.855

Use of steroids

 Yes

 No

151 (55.9)

119 (44.1)

53 (61.6)

33 (38.4)

21 (52.5)

19 (47.5)

77 (53.5)

67 (46.5)

0.432

Outcome

 Improved

270 (100)

86 (100)

40 (100)

144 (100)

 
  1. A Data are presented as mean ± SD for quantitative variables and number (%) for categorical data. Significance is considered when P-value < 0.05